Testosterone Replacement Therapy Market to Record a CAGR of 3.1%, Rise in Novel Therapeutic Approaches to be a Key Trend - Technavio

NEW YORK, Sept. 26, 2022 /PRNewswire/ -- One of the key trends in the testosterone replacement therapy market is the rise in novel therapeutic approaches. Metabolic syndrome can result in testosterone deficiency. It can be treated with anti-inflammatory drugs, which are also used to treat testosterone deficiency. The advent of new therapeutic approaches is leading to frequent market changes. Vendors are focusing on developing alternative treatment options. Thus, the growing focus of vendors on therapeutic approaches is expected to lead to the entry of new products in the global testosterone replacement therapy market, which will drive market growth.

The testosterone replacement therapy market size is expected to grow by USD 402.87 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 3.1% during the forecast period, according to Technavio.

Get a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format

The initiatives to raise awareness about hypogonadism among the population are driving the growth of the testosterone replacement therapy market. However, factors such as the availability of generics may challenge market growth.

Testosterone Replacement Therapy Market: Product Landscape

By product, the market has been segmented into injectables, topicals, and others. The injectables segment will be the largest contributor to market growth during the forecast period. This growth is attributed to factors such as the prevalence of testosterone deficiency. Some of the major conditions that have been identified as risk factors for testosterone deficiency include diabetes, obesity, metabolic syndrome, and dyslipidemia. Therefore, the rise in the prevalence of testosterone deficiency is expected to accelerate the growth of the global testosterone replacement therapy market during the forecast period.

Testosterone Replacement Therapy Market: Geographic Landscape

By geography, the market has been segmented into North America, Europe, Asia, and the Rest of the World (ROW). North America is expected to have lucrative growth during the forecast period. About 58% of the market's overall growth is expected to originate from the region. The US and Canada are the key countries for the testosterone replacement therapy market in North America. The growth of the region is attributed to factors such as the rising number of cases of hypogonadism and raising awareness about the treatment of testosterone deficiency and erectile dysfunction.

Companies Covered

• AbbVie Inc.
• Acerus Pharmaceuticals Corp.
• Acrux Ltd.
• Actiza Pharmaceutical Pvt. Ltd.
• Antares Pharma Inc.
• Aytu BioPharma Inc.
• Bausch Health Co. Inc.
• Bayer AG
• BIOTE MEDICAL LLC
• Cipla Ltd.
• Clarus Therapeutics Inc.
• Eli Lilly and Co.
• Endo International Plc
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• The Simple Pharma Co. UK Ltd.
• Upsher Smith Laboratories LLC
• Viatris Inc.

This report provides a full list of key vendors, their strategies, and the latest developments. Request a FREE PDF Sample Now

What our reports offer

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers market data for 2022, 2022, until 2026
• Market trends (opportunities, drivers, threats, challenges, investment opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping highlighting the key common trends
• Company profiling with detailed strategies, recent developments, and financials
• Supply chain trends recording the latest technological advancements

Related Reports

Sexually Transmitted Diseases (STD) Treatment Market by Service and Geography - Forecast and Analysis 2022-2026: The sexually transmitted diseases (STD) treatment market share is expected to increase by USD 13.48 billion from 2021 to 2026.

Sexual Enhancement Supplements Market by Product and Geography - Forecast and Analysis 2022-2026: The sexual enhancement supplements market share is expected to increase by USD 801.29 million from 2021 to 2026.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments 
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

• 5.2 Comparison by Product 
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product

• 5.3 Injectables - Market size and forecast 2021-2026
• Exhibit 28: Chart on Injectables - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Injectables - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Injectables - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Injectables - Year-over-year growth 2021-2026 (%)

• 5.4 Topicals - Market size and forecast 2021-2026
• Exhibit 32: Chart on Topicals - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Topicals - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Topicals - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Topicals - Year-over-year growth 2021-2026 (%)

• 5.5 Others - Market size and forecast 2021-2026
• Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Product 
• Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Canada - Market size and forecast 2021-2026
• Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.9 Germany - Market size and forecast 2021-2026
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.11 China - Market size and forecast 2021-2026
• Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape 
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption 
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks 
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered 
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 88: Matrix on vendor position and classification

• 10.3 AbbVie Inc. 
• Exhibit 89: AbbVie Inc. - Overview
• Exhibit 90: AbbVie Inc. - Product / Service
• Exhibit 91: AbbVie Inc. - Key offerings

• 10.4 Acerus Pharmaceuticals Corp. 
• Exhibit 92: Acerus Pharmaceuticals Corp. - Overview
• Exhibit 93: Acerus Pharmaceuticals Corp. - Product / Service
• Exhibit 94: Acerus Pharmaceuticals Corp. - Key offerings

• 10.5 Antares Pharma Inc. 
• Exhibit 95: Antares Pharma Inc. - Overview
• Exhibit 96: Antares Pharma Inc. - Product / Service
• Exhibit 97: Antares Pharma Inc. - Key news
• Exhibit 98: Antares Pharma Inc. - Key offerings

• 10.6 Bayer AG 
• Exhibit 99: Bayer AG - Overview
• Exhibit 100: Bayer AG - Business segments
• Exhibit 101: Bayer AG - Key offerings
• Exhibit 102: Bayer AG - Segment focus

• 10.7 Clarus Therapeutics Inc. 
• Exhibit 103: Clarus Therapeutics Inc. - Overview
• Exhibit 104: Clarus Therapeutics Inc. - Product / Service
• Exhibit 105: Clarus Therapeutics Inc. - Key offerings

• 10.8 Eli Lilly and Co. 
• Exhibit 106: Eli Lilly and Co. - Overview
• Exhibit 107: Eli Lilly and Co. - Product / Service
• Exhibit 108: Eli Lilly and Co. - Key offerings

• 10.9 Endo International Plc 
• Exhibit 109: Endo International Plc - Overview
• Exhibit 110: Endo International Plc - Business segments
• Exhibit 111: Endo International Plc - Key news
• Exhibit 112: Endo International Plc - Key offerings
• Exhibit 113: Endo International Plc - Segment focus

• 10.10 Novartis AG 
• Exhibit 114: Novartis AG - Overview
• Exhibit 115: Novartis AG - Business segments
• Exhibit 116: Novartis AG - Key offerings
• Exhibit 117: Novartis AG - Segment focus

• 10.11 Pfizer Inc. 
• Exhibit 118: Pfizer Inc. - Overview
• Exhibit 119: Pfizer Inc. - Product / Service
• Exhibit 120: Pfizer Inc. - Key news
• Exhibit 121: Pfizer Inc. - Key offerings

• 10.12 The Simple Pharma Co. UK Ltd. 
• Exhibit 122: The Simple Pharma Co. UK Ltd. - Overview
• Exhibit 123: The Simple Pharma Co. UK Ltd. - Product / Service
• Exhibit 124: The Simple Pharma Co. UK Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 125: Inclusions checklist
• Exhibit 126: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 127: Currency conversion rates for US$

• 11.4 Research methodology 
• Exhibit 128: Research methodology
• Exhibit 129: Validation techniques employed for market sizing
• Exhibit 130: Information sources

• 11.5 List of abbreviations 
• Exhibit 131: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio